ISSN 1673-3770 CN 37-1437/R
山东大学耳鼻喉眼学报 ›› 2017, Vol. 31 ›› Issue (6): 16-20.doi: 10.6040/j.issn.1673-3770.1.2017.040
• 甲状腺癌的规范化诊断与治疗·专题笔谈 • 上一篇 下一篇
孙滨,郭伯敏,康杰,邓先兆,伍波,樊友本
SUN Bin, GUO Bomin, KANG Jie, DENG Xianzhao, WU Bo, FAN Youben
摘要： 甲状腺未分化癌是恶性程度最高的甲状腺肿瘤,侵袭性高,转移早,预后极差。目前临床上采用手术、放疗、化疗及靶向治疗等方式进行综合治疗,但尚未有十分有效的规范化治疗方案,结合该院诊治经验,探索甲状腺未分化癌的规范化治疗。
中图分类号:
| [1] Kebebew E, Greenspan FS, Clark OH, et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors[J]. Cancer, 2005,103(7):1330-1335. [2] Wendler J, Kroiss M, Gast K, et al. Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in germany[J]. Eur J Endocrinol, 2016, 175(6):521-529. [3] Segerhammar I, Larsson C, Nilsson IL, et al. Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution[J]. J Surg Oncol, 2012, 106(8):981-986. [4] Smallridge RC, Ain KB, Asa SL, et al. American thyroid association guidelines for management of patients with anaplastic thyroid cancer[J]. Thyroid, 2012, 22(11):1104-1139. [5] Haddad RI, Lydiatt WM, Ball DW, et al. Anaplastic thyroid carcinoma, version 2.2015[J]. J Natl Compr Canc Netw, 2015, 13(9):1140-1150. [6] Zivaljevic V, Tausanovic K, Paunovic I, et al. Age as a prognostic factor in anaplastic thyroid cancer[J]. Int J Endocrinol, 2014: 240513. [7] Akaishi J, Sugino K, Kitagawa W, et al. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma[J]. Thyroid, 2011, 21(11):1183-1189. [8] Sugitani I, Miyauchi A, Sugino K, et al. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: Atc research consortium of japan cohort study of 677 patients[J]. World J Surg, 2012, 36(6):1247-1254. [9] Yoshida A, Matuzu K. Analysis of long-term survivors in anaplastic thyroid carcinoma[J]. Nihon Geka Gakkai Zasshi, 2012, 113(4):373-377. [10] Sugitani I, Hasegawa Y, Sugasawa M, et al. Super-radical surgery for anaplastic thyroid carcinoma: a large cohort study using the anaplastic thyroid carcinoma research consortium of japan database[J]. Head Neck, 2014, 36(3):328-333. [11] 张宗敏, 徐震纲, 唐平章, 等. 重新认识甲状腺未分化癌[J]. 中国医学科学院学报, 2006,28(3):322-324. ZHANG Zongmin, XU Zhengang, TANG Pingzhang, et al. A retrospective analysis of anaplastic thyroid carcinoma[J]. Act Acad Med Sin, 2006, 28(3):322-324. [12] Pierie JP, Muzikansky A, Gaz RD, et al. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma[J]. Ann Surg Oncol, 2002, 9(1):57-64. [13] Sun C, Li Q, Hu Z, et al. Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in china[J]. PloS one, 2013, 8(11):80011. [14] Sherman EJ, Lim SH, Ho AL, et al. Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review[J]. Radiother Oncol, 2011, 101(3):425-430. [15] 房居高. 强化手术技能和规范诊疗是提高甲状腺癌疗效的根本[J]. 山东大学耳鼻喉眼学报,2016, 30(2):1-4. FANG Jugao. Operation skill and standard diagnosis and treatment are the basics of improving the curative effect of thyroid carcinoma[J]. J Otolaryngol Ophthal Shandong Univ, 2016, 30(2):1-4. [16] Zhou M, Chen Y, Adachi M, et al. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer[J]. Biomaterials, 2015, 57:41-49. [17] Bhatia A, Rao A, Ang KK, et al. Anaplastic thyroid cancer: clinical outcomes with conformal radiotherapy[J]. Head Neck, 2010, 32(7):829-836. [18] Lowe NM, Loughran S, Slevin NJ, et al. Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival-a single centre experience and review of the literature[J]. Sci World J, 2014: 674583. [19] Seto A, Sugitani I, Toda K, et al. Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases[J]. Surg Today, 2015, 45(2):221-226. [20] Savvides P, Nagaiah G, Lavertu P, et al. Phase ii trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid[J]. Thyroid, 2013, 23(5):600-604. [21] Wein RO, Weber RS. Anaplastic thyroid carcinoma: Palliation or treatment?[J]. Curr Opin Otolaryngol Head Neck Surg, 2011, 19(2):113-118. [22] Pennell NA, Daniels GH, Haddad RI, et al. A phase ii study of gefitinib in patients with advanced thyroid cancer[J]. Thyroid, 2008, 18(3):317-323. |
| [1] | 王坛,武珂,李连庆,宫丽丽. 皮下免疫治疗注射后出现全身不良反应的伴发因素及处理[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 71-74. |
| [2] | 吴静,刘业海. 头颈部鳞状细胞癌的靶向治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 97-102. |
| [3] | 沈勤峰,沈小燕,朱荣强,蒋斐斐,郎军添. 鼻内镜下中鼻甲功能性部分切除治疗慢性鼻窦炎76例分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 82-85. |
| [4] | 代亚错,李靖,万保罗,臧艳姿,黄颖铭. 个体化治疗咽喉部海绵状血管瘤二例[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 110-112. |
| [5] | 刘义平,林远超. 负压引流防治腮腺术后涎瘘112例[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 65-67. |
| [6] | 陈鸣,俞雪飞. 浅谈伴有变应性鼻炎的慢性鼻窦炎的治疗[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 18-22. |
| [7] | 张桂敏,林鹏. 慢性鼻-鼻窦炎的内在型:从基础到临床[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 14-17. |
| [8] | 覃纲,梁灼萍. 变应性真菌性鼻-鼻窦炎免疫治疗现状[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 23-26. |
| [9] | 吴湘萍. 患者管理方式对变应性鼻炎舌下含服粉尘螨滴剂疗效的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 68-72. |
| [10] | 高进良,年婉清,李烁. 鼻内镜手术联合鼻用糖皮质激素治疗腺样体肥大性[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 38-42. |
| [11] | 王仙,李颖,赵博军. 息肉样脉络膜血管病变诊疗进展[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 103-106. |
| [12] | 吕丹,李明霞,马兰枝,张馨元,肖浩,陈飞,刘均,李珍. 累及纵膈的头颈部丛状I型神经纤维瘤病两例[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 82-86. |
| [13] | 陈红,曹慧玲,窦鑫,高下. 右侧鼻腔小细胞神经内分泌癌一例并文献复习[J]. 山东大学耳鼻喉眼学报, 2018, 32(1): 89-92. |
| [14] | 敬尚林. 儿童上气道咳嗽综合征临床诊疗现状[J]. 山东大学耳鼻喉眼学报, 2017, 31(6): 87-91. |
| [15] | 张玉波,岳丽艳,尹晓妍,吕哲,单春光. 耳鸣治疗仪联合银杏叶提取物注射液治疗突聋伴耳鸣的疗效分析[J]. 山东大学耳鼻喉眼学报, 2017, 31(5): 50-53. |
|